
DPI is a leading strategic and investment intelligence agency focused on the emerging markets in #Pharma #BioTech #HealthCare | https://xitter.cf/t.co/L4t5hnpsPJ
London, England
Joined November 2020
- Tweets762
- Following31
- Followers265
- Likes28
Turkey's life science sector is growing, with 1,440 companies and a focus on Longevity Medicine. Supported by 45 investors and 40 tech investors: eu1.hubs.ly/H07_YSV0
Regional stakeholders interested in having their own ecosystem mapping platform: ecosystem-map.info
Leveraging a dynamic Life Sciences Ecosystem, the United Arab Emirates has cemented its status as a burgeoning hub for innovation: eu1.hubs.ly/H083NdG0
Regional stakeholders interested in having their own ecosystem mapping platform developed: eu1.hubs.ly/H083Zb70
Leveraging a dynamic Life Sciences Ecosystem, the United Arab Emirates has cemented its status as a burgeoning hub for innovation.
Explore the insights and join the conversation at eu1.hubs.ly/H07R8FC0
#LifeSciencesUAE #Innovation #HealthTech #Biotech #UAELeadership
Deep Knowledge Group’s Life Sciences Division has launched a first-of-its-kind mapping of the Turkey Life Sciences Ecosystem.
Explore the Turkey Life Sciences Ecosystem Platform here: eu1.hubs.ly/H07LPVY0
Deep Knowledge Group Life Sciences Division has launched a first-of-its-kind mapping of the UAE Life Sciences Ecosystem.
Explore the UAE Life Sciences Ecosystem Platform here: eu1.hubs.ly/H07KX2Y0
Deep Pharma Intelligence is pleased to have its Pharma AI industry analytics research featured in a recent article on biology-driven AI in @Forbes by @Niven_Narain
Read the full article here: eu1.hubs.ly/H07CY7Y0
Deep Pharma Intelligence is delighted to be featured also in Portuguese by @BloombergLineaB
Read the full article here eu1.hubs.ly/H06pX3v0
@InSilicoMeds Kanoko Matsuyama
#Bloomberg #AI #Pharma
Deep Pharma Intelligence's AI research featured in @Bloomberg highlights @InSilicoMeds's groundbreaking AI-discovered drug for idiopathic pulmonary fibrosis, significantly cutting development time and costs.
Read the full article in Bloomberg here: eu1.hubs.ly/H06cSHx0
Discover the AI in Mental Health Platform and report from @AgingAnalytics. Featuring 70 AI companies, 70 investors, 20 hubs, and 20 leaders, the report dives into the growing AI industry and its impact on mental health eu1.hubs.ly/H068GVD0
#AIMentalHealth #AI
AI is revolutionizing the healthcare industry - Analytical Algorithms lead the way with 56%, Early Diagnostic Devices at 14%, Digital Patient Models at 12%, and the dynamic 'Other' category at 18% eu1.hubs.ly/H05YN8L0
#AI #EarlyDiagnostics #HealthTech #Innovation
Discover the Top 50 AI Experts in Early Diagnostics on our interactive platform. Learn more here: eu1.hubs.ly/H05YpdW0
Learn more at our AI in Early Diagnostics Platform: eu1.hubs.ly/H05Yny40
#ai #EarlyDiagnostics #AIinHealthcare #InnovationsInMedicine
Explore the Early Diagnostics Interactive Network: 120 companies, 300 investors, and 20 key hubs advancing Early Diagnostics technologies. Dive deeper into the Early Diagnostics Interactive Network: eu1.hubs.ly/H05Y1mP0
#ai #EarlyDiagnostics #AIinHealthcare
Deep Pharma Intelligence introduces its AI in Early Diagnostics Platform and report: 120 leading companies, 300 investors, 20 innovation hubs, 50 innovators, insights on diagnostic tech, disease detection, AI, and more!
Learn more at: eu1.hubs.ly/H05XT3g0
#ai #EarlyDiagnostics
Integrating 3D organoid models can streamline drug development, reducing duds in costly clinical trials and paving the way for more approved medications. For more insights, please visit our AI in Organoids and Organ-on-a-Chip Platform: eu1.hubs.ly/H05PRvW0
#ai #Organoids
Aging Analytics Agency presents its AI in Biomarkers Platform, offering insights on 110 companies, 340 investors, and 20 hubs, with profiles of the Top 100 Biomarkers Innovators.
Learn more at: eu1.hubs.ly/H05Rls70
#AI #Biomarkers #HealthcareInnovation #PrecisionMedicine
The world of Organoids and Organ-on-a-Chip technology is truly global, with diverse investors from US, Switzerland, Belgium, Netherlands, Canada, UK, Israel, China, Hong Kong, Germany, South Korea, Singapore fueling innovation!
eu1.hubs.ly/H05QctL0
#Organoids #OrganOnAChip
Check out our dynamic database of the Top 100 AI Leaders in Organoids and Organ-on-a-Chip! Explore to find distinguished researchers, investors, entrepreneurs, and innovators committed to harnessing AI to address complex challenges. Explore: eu1.hubs.ly/H05Pf0M0
#AI #Pharma
AI in Organoids and Organ-on-a-Chip Platform provides a holistic view of the field, featuring interactive profiles, visualized networks, and extensive data on 17 companies, 66 investors, and 17 key hubs, classified into three pivotal domains eu1.hubs.ly/H05NJvr0
#AI #Organoids
Introducing our AI in Organoids & Organ-on-a-chip report with valuable insights for industry pros, decision-makers, and enthusiasts, highlighting the Top 100 Innovators.
Learn more at: eu1.hubs.ly/H05NH4b0
#AI #Organoids #Pharma
The UAE is becoming a hub for clinical trials, with pharmaceutical giants like @novonordisk, @Sanofi , @AstraZeneca, and @Pfizer collaborating with local medical facilities to develop cutting-edge medical therapies. Learn more at eu1.hubs.ly/H05LgXm0
#ai #uae #Diabetes













